Application 050461

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ANCEFCEFAZOLIN SODIUMINJECTABLE;INJECTIONEQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002ANCEFCEFAZOLIN SODIUMINJECTABLE;INJECTIONEQ 500MG BASE/VIALYesNo
003ANCEFCEFAZOLIN SODIUMINJECTABLE;INJECTIONEQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004ANCEFCEFAZOLIN SODIUMINJECTABLE;INJECTIONEQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
005ANCEFCEFAZOLIN SODIUMINJECTABLE;INJECTIONEQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
7759SUPPL2005-01-11
38944SUPPL2004-06-07
30037SUPPL2004-06-07
30036SUPPL2004-01-22
17837SUPPL2004-01-22